Rapid Maturation of Effector T Cells in Tumors
Author Information
Author(s): Norian Lyse A., Allen Paul M.
Primary Institution: Washington University School of Medicine
Hypothesis
How does the entry of effector T cells into tumor microenvironments affect their maturation and function?
Conclusion
Effector T cells in tumors undergo rapid maturation and increased cytolytic capacity, but also experience decreased viability.
Supporting Evidence
- Effector T cells in tumors showed a rapid transition to a more mature phenotype.
- Cytolytic activity of T cells increased during tumor regression.
- T cells in lymphoid organs did not show similar maturation or changes in cytolytic activity.
Takeaway
When T cells go into tumors, they get better at fighting cancer but also start to die faster.
Methodology
Adoptive transfer of tumor antigen-specific T cells into tumor-bearing mice, followed by evaluation of T cell phenotype, function, and survival.
Potential Biases
Potential bias in interpreting results due to the specific tumor model and the controlled experimental conditions.
Limitations
The study used a specific tumor model (CMS5 fibrosarcoma), which may not represent all tumor types.
Participant Demographics
Mice (DUC18 TCR transgenic on a BALB/c background).
Statistical Information
P-Value
0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website